Successful Management of Netherton Syndrome Using IVIG and Dupilumab: A Case Report

    April 2025
    Reshale Johar, R Rajab, Amer Khojah, Loie Goronfolah
    Studysummary In this case report, a 7-month-old boy with Netherton syndrome experienced significant improvement in symptoms, including reduced pruritus and increased hair growth, through a combination of intravenous immunoglobulin and dupilumab treatment, which also decreased high serum IgE levels and food-specific IgE antibodies.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on rupress.org →
    Discuss this study in the Community →